Nasdaq
MAZE
Maze Therapeutics, Inc.
- Health Care
- Listed 2025
- 1 day
- +2.6%
- 1 month
- −13.1%
- 1 year
- +100%
$28.53 · Mkt cap $1.58B
At the 6 Aug 2026 close
Nasdaq
Maze Therapeutics, Inc.
$28.53 · Mkt cap $1.58B
At the 6 Aug 2026 close
Maze Therapeutics, Inc. trades under the ticker MAZE on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2025. Its market capitalisation is $1.58B. The last closing price was $28.53, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +100%, and −13.1% over the past month. Returns are price returns and exclude dividends.
This page exists because MAZE is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.